Ted Quiroz Director, Global Clinical Supply Chain Amgen Inc.
|
|
- Clinton Banks
- 8 years ago
- Views:
Transcription
1 Ted Quiroz Director, Global Clinical Supply Chain Amgen Inc.
2 to serve patients Enbrel (etanercept) EPOGEN (Epoetin alfa) Aranesp (Darbepoetin alfa) Sensipar (cinacalcet HCl) Vectibix (panitumumab)
3 We aspire to be the best human therapeutics company. We will live the Amgen values and use science and innovation to dramatically improve people s lives. Our Goals Deliver the Best Pipeline- Corporate Build the Best Pipeline- Operations Supply Every Patient Every Time- Operations
4 How does a company develop 28 therapies, conduct over 200 clinical trials, serve over 40,000 patients, in 48 countries?
5 & $ (!! " $ ( ( % $ ' $ # & $ $ % " # "!!! Phase 1 ( & % $ $ -. - ( &! $ ( # #! $ ( * * + & ", " # * * " # # * * )! ) Phase 2! %! $ ( & ' (! %! %!# ) " # # Phase 3
6 ! " Clinical trials entering unfamiliar, recently developing infrastructures Fierce competition for enrolling new patients globally Sustaining cold or frozen shipments through multi-connection international locations The movement of biologics differs significantly compared to small molecule Ambient products are easier to move- Maintaining temperature is critical Less concern about shock and vibe- Proteins are more sensitive Stability profile takes longer to establish Transport validation potentially complex, nontransparent lanes Safely securing comparator products through international sources Keen global partner management tactics Coordination across opposite time zones Awareness of cultural differences Infrastructure- Limited presence globally
7 In our company, Global Clinical Supply Chain Management plays a key role in coordinating and managing the variables related to Amgen s pipeline from concept to delivery Gather requirements with R&D- Review demand and set forecasts Plan overall study needs- Pre-clinical and Clinical Build inventories working with Manufacturing Define label and packaging needs Work with partners to ensure delivery of product Transportation Distribution Provide ongoing Support- Customer Service Systems- IVR set up, testing and issue management Reconciliation Manage daily activities with depots in LA, Asia, and NA Clinical Supply Chain Management plays an expanded role compared to traditional roles from other companies
8 # $ " " %& ' With entry into new countries, it is critical to define the supply chain needs To manage multiple countries, multiple products, different country requirements Solution: Develop cross Functional Study Teams Aligned through therapeutic areas and products Global Regulatory Affairs provides critical information per country Transportation lanes- Qualification process Preferred vendors versus in country expertise ImportExport needs Dedicated experts In country experts- consultants and CROs Utilize vendors that best meet your need- Expertise still emerging Cold Chain Reliability- Fully understand cold chain products Demonstrate competency to reduce product risk- Contingency planning Execute accurate, detailed contracts with vendors- KPIs Note: Rapid growth can lead to missing the details
9 $ " " %& ' Competition for new patients globally- Enter new countries quickly and efficiently Expanded label content In-house labeling and packaging operations Amgen Distribution Centers Master service agreements Movement of Refrigerated and Frozen drug product Transport validation- Robust testing program Transport Packaging Configurations- Manufacturing in global locations Provide packaging materials to support trials- depots or LSPs Securing Comparators globally Source local when possible- Improve distribution lead times and costs Minimize re-labeling when possible Ensure blinding strategy can be supported- 2-8 C versus ambient pack outs Partner relationships Infrastructure- Expand presence globally through partners Time zone differences- Meet partners regularly Cultural differences- Understand the do s and don ts
10 Back up
11 ' Be science-based Compete intensely and win Work in teams Create value for patients, staff, and stockholders Trust and respect each other Ensure quality Collaborate, communicate, and be accountable Be ethical
12 (" 1980: 1985: 1991: 1994: 2002: 2005: Amgen founded (original name: AMGen) NEUPOGEN (Filgrastim) discovered NEUPOGEN launched, named Product of the Year by Fortune Magazine Amgen receives US Department of Commerce National Medal of Technology Neulasta (pegfilgrastim) launched Amgen acquired Immunex, including ENBREL Kepivance (palifermin) launched : 1989: 2001: 2004: IPO (Ticker Symbol: AMGN) EPOGEN (Epoetin alfa) discovered Enbrel (etanercept) discovered by Immunex EPOGEN launched, named Product of the Year by Fortune Magazine Aranesp (darbepoetin alfa) launched Sensipar (cinacalcet HCl) launched Tularik acquisition completed
13 ( This presentation contains forward-looking statements that are based on management s current expectations and beliefs and are subject to a number of risks, uncertainties and assumptions that could cause actual results to differ materially from those described. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements, including estimates of revenues, operating margins, capital expenditures, cash, other financial metrics, expected legal, arbitration, political, regulatory or clinical results or practices, customer and prescriber patterns or practices, reimbursement activities and outcomes and other such estimates and results. Forward-looking statements involve significant risks and uncertainties, including those discussed below and more fully described in the Securities and Exchange Commission (SEC) reports filed by Amgen, including Amgen s most recent annual report on Form 10-K and most recent periodic reports on Form 10-Q and Form 8-K. Please refer to Amgen s most recent Forms 10-K, 10-Q and 8-K for additional information on the uncertainties and risk factors related to our business. Unless otherwise noted, Amgen is providing this information as of January 25, 2007 and expressly disclaims any duty to update information contained in this presentation. No forward-looking statement can be guaranteed and actual results may differ materially from those we project. The Company s results may be affected by our ability to successfully market both new and existing products domestically and internationally, clinical and regulatory developments (domestic or foreign) involving current and future products, sales growth of recently launched products, competition from other products (domestic or foreign), difficulties or delays in manufacturing our products. In addition, sales of our products are affected by reimbursement policies imposed by third-party payors, including governments, private insurance plans and managed care providers and may be affected by regulatory, clinical and guideline developments and domestic and international trends toward managed care and health care cost containment as well as U.S. legislation affecting pharmaceutical pricing and reimbursement. Government and others regulations and reimbursement policies may affect the development, usage and pricing of our products. Furthermore, our research, testing, pricing, marketing and other operations are subject to extensive regulation by domestic and foreign government regulatory authorities. We or others could identify safety, side effects or manufacturing problems with our products after they are on the market. Our business may be impacted by government investigations, litigation and products liability claims. Further, while we routinely obtain patents for our products and technology, the protection offered by our patents and patent applications may be challenged, invalidated or circumvented by our competitors. We depend on third parties for a significant portion of our manufacturing capacity for the supply of certain of our current and future products and limits on supply may constrain sales of certain of our current products and product candidate development. In addition, we compete with other companies with respect to some of our marketed products as well as for the discovery and development of new products. Discovery or identification of new product candidates cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate will be successful and become a commercial product. Further, some raw materials, medical devices and component parts for our products are supplied by sole third-party suppliers. This presentation includes GAAP and non-gaap financial measures. In accordance with the requirements of SEC Regulation G, reconciliations between these two measures, if these slides are in hardcopy, accompany the hardcopy presentation or, if these slides are delivered electronically, are available on the Company's website at within the Investors section.
PATIENT APPLICATION FORM INSTRUCTIONS
INSTRUCTIONS The Safety Net Foundation is a nonprofit patient assistance program that helps qualifying uninsured patients access Amgen medicines at no cost. To apply online, access program information
More informationQ2 15 Earnings Call. July 30, 2015
Q2 15 Earnings Call July 30, 2015 Safe Harbor Statement This presentation contains forward-looking statements that are based on management s current expectations and beliefs and are subject to a number
More informationAdoption of Business Net Income
Adoption of Business Net Income 1 Forward Looking Statements This presentation contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking
More informationThird-Quarter 2015 Earnings Conference Call Executive Commentary Highlights. October 27, 2015
Third-Quarter 2015 Earnings Conference Call Executive Commentary Highlights October 27, 2015 Forward-Looking Statement of Merck & Co., Inc., Kenilworth, N.J., USA This presentation of Merck & Co., Inc.,
More informationChallenging quarter for Mobile Devices. Daily order rates improving. Free Cash Flow > Net Income. FCT acquisition. Page 3
August 7, 2013 Page 1 Statements in this release that are not historical are forward-looking and are subject to various risks and uncertainties that could cause actual results to vary materially from those
More informationPerformance Food Group Company Reports First-Quarter Fiscal 2016 Earnings
NEWS RELEASE For Immediate Release November 4, 2015 Investors: Michael D. Neese VP, Investor Relations (804) 287-8126 michael.neese@pfgc.com Media: Joe Vagi Manager, Corporate Communications (804) 484-7737
More informationBest Practice Approaches to Improving Clinical Supply Chain Management. Matthew Do Client Development Lead Almac Pharmaceutical Services
Best Practice Approaches to Improving Clinical Supply Chain Management Matthew Do Client Development Lead Almac Pharmaceutical Services A variety of challenges complicate trial supply management Multiple
More informationXENOPORT INC FORM 8-K. (Current report filing) Filed 05/08/14 for the Period Ending 05/08/14
XENOPORT INC FORM 8-K (Current report filing) Filed 05/08/14 for the Period Ending 05/08/14 Address 3410 CENTRAL EXPRESSWAY SANTA CLARA, CA 95051 Telephone 4086167200 CIK 0001130591 Symbol XNPT SIC Code
More informationFlamel Technologies Announces Second Quarter Results of Fiscal Year 2015
Flamel Technologies Announces Second Quarter Results of Fiscal Year 2015 Product revenue guidance for 2015 of $170-$185 million reaffirmed Conference call with management to take place at 10:00 am ET on
More information2013 Letter from Our Chairman & CEO
2013 Letter from Our Chairman & CEO In fiscal 2013, we extended our track record of creating exceptional shareholder value. Pierre Nanterme Chairman & CEO Delivering in fiscal 2013 In fiscal 2013, Accenture
More information2012 Letter from Our Chief Executive Officer
2012 Letter from Our Chief Executive Officer Our strong performance in fiscal 2012 demonstrates that our growth strategy enabled us to further differentiate Accenture in the marketplace and deliver significant
More informationEDWARDS LIFESCIENCES REPORTS STRONG FIRST QUARTER RESULTS DRIVEN BY SALES GROWTH OF 18.8 PERCENT
Edwards Lifesciences Corporation One Edwards Way Irvine, CA USA 92614 Phone: 949.250.2500 Fax: 949.250.2525 www.edwards.com FOR IMMEDIATE RELEASE Media Contact: Amanda C. Fowler, 949-250-5070 Investor
More informationClinical Trial Management Systems Survey
Clinical Trial Management Systems Survey Conducted: January 2013 : Cambridge Healthtech Media Group 250 First Avenue, Suite 300, Needham, Massachusetts 02494 T: 781-972-5400 or toll-free in the U.S. 888-999-6288
More informationVerifone Reports Results for the Second Quarter of Fiscal 2016
Verifone Reports Results for the Second Quarter of Fiscal 2016 SAN JOSE, Calif. (BUSINESS WIRE) Verifone (NYSE: PAY), a world leader in payments and commerce solutions, today announced financial results
More informationVeritiv Corporation 2Q14 Financial Results. August 13, 2014
Veritiv Corporation 2Q14 Financial Results August 13, 2014 Safe Harbor Provision Certain statements contained in this presentation regarding Veritiv Corporation s (the Company ) future operating results,
More informationThe Board reviews risks to the Company s business plan at its scheduled meetings.
Pharmaxis Ltd 1. Board responsibility The Pharmaxis Board is responsible for ensuring the Company establishes and maintains a risk management framework for the oversight and management of risk. The Board
More informationLockheed Martin Corporation
Lockheed Martin Corporation 3 rd Quarter 2015 Financial Results Conference Call 11:00 am EDT Webcast login at www.lockheedmartin.com/investor Webcast replay & podcast available by 2:00 p.m. EDT at www.lockheedmartin.com/investor.
More informationFortinet Reports Strong Third Quarter 2015 Financial Results. Record billings growth of 41% year over year
Press Release Investor Contact: Media Contact: Michelle Spolver Sandra Wheatley Fortinet, Inc. Fortinet, Inc. 408-486-7837 408-391-9408 mspolver@fortinet.com swheatley@fortinet.com Fortinet Reports Strong
More informationBlackBerry Reports Strong Software Revenue and Positive Cash Flow for the Fiscal 2016 First Quarter
FOR IMMEDIATE RELEASE June 23, BlackBerry Reports Strong Software Revenue and Positive Cash Flow for the Fiscal 2016 First Quarter Waterloo, ON BlackBerry Limited (NASDAQ: BBRY; TSX: BB), a global leader
More informationCATAMARAN CORPORATION ANNOUNCES RECORD FINANCIAL RESULTS FOR 2014 CATAMARAN TO ACQUIRE HEALTHCARE SOLUTIONS, INC.
CATAMARAN CORPORATION ANNOUNCES RECORD FINANCIAL RESULTS FOR 2014 CATAMARAN TO ACQUIRE HEALTHCARE SOLUTIONS, INC. Schaumburg, Illinois, February 26, 2015 - Catamaran Corporation ( Catamaran or the Company
More informationLorna Briddick Managing Partner Brizzey LLC. 10/30/2014 October 30, 2014 1
Global Clinical Supplies & The Road Less Traveled: Navigating the bumps, pot holes and detours that come with the development and delivery of Investigational Products Lorna Briddick Managing Partner Brizzey
More information4Q and FYE 2014 Results Conference Call
A global environmental technology company focused on air pollution control, energy, fluid handling and filtration industries 4Q and FYE 2014 Results Conference Call March 5, 2015 1 Safe Harbor Statement
More informationMark Rohlfing. Vice President of Operations Almac Clinical Services Souderton, Pennsylvania
Mark Rohlfing Vice President of Operations Almac Clinical Services Souderton, Pennsylvania Confidential Almac Group 2014 Who We Are Almac is a global drug development services provider. Our mission is
More informationSpectra Energy Reports Fourth Quarter and Year-End 2007 Results
Media: Molly Boyd (713) 627-5923 (713) 627-4747 (24-hour media line) Analysts: John Arensdorf (713) 627-4600 Date: February 6, 2008 Spectra Energy Reports Fourth Quarter and Year-End 2007 Results Fourth
More informationHewlett-Packard Separation Will Create Two New Industry-Leading Public Companies
Hewlett-Packard Separation Will Create Two New Industry-Leading Public Companies Investor Presentation October 6, 2014 Safe harbor This presentation contains forward-looking statements that involve risks,
More informationSpectra Energy Reports First Quarter 2012 Results
Media: Analysts: Wendy Olson (713) 627-4072 (713) 627-4747 (24-hour media line) John Arensdorf (713) 627-4600 Date: May 4, 2012 Spectra Energy Reports First Quarter 2012 Results Reported net income from
More informationJefferies Healthcare Conference
Jefferies Healthcare Conference Marc Naughton Executive Vice President and Chief Financial Officer June 2, 2015 Safe Harbor Statement This presentation may contain forward-looking statements, including
More informationZynga Q1 14 Financial Results April 23, 2014
Zynga Q1 14 Financial Results April 23, 2014 1 Table of Contents Discussion of Q1 14 Performance Q2 14 and FY2014 Financial Outlook GAAP to Non-GAAP Reconciliation 2 Management Team Don Mattrick Chief
More informationQ2 2015 Financial Results and Key Metrics
Q2 2015 Financial Results and Key Metrics August 13, 2015 Non-GAAP financial measures King Digital Entertainment plc (the Company ) uses International Financial Reporting Standards ( IFRS ). In addition
More informationAPX GROUP HOLDINGS, INC. REPORTS FIRST QUARTER 2015 RESULTS
APX GROUP HOLDINGS, INC. REPORTS FIRST QUARTER 2015 RESULTS First Quarter 2015 Financial and Portfolio Highlights APX Group Reports Total Revenue of $149.9 Million, up 14.9% Year over Year Adjusted EBITDA
More informationSpectra Energy Reports First Quarter 2009 Results
Media: Analysts: Wendy Olson (713) 627-4072 (713) 627-4747 (24-hour media line) John Arensdorf (713) 627-4600 Date: May 5, 2009 Spectra Energy Reports First Quarter 2009 Results Reported net income (controlling
More informationGlobal Supply. 17 November 2011
Global Supply 17 November 2011 David Gosnell President, Global Supply and Procurement Supply goals: Enhancing margin and enabling growth Competitive advantage in cost will deliver gross margin expansion
More informationNumerex Reports First Quarter 2015 Financial Results
May 11, 2015 Numerex Reports First Quarter 2015 Financial Results ATLANTA, May 11, 2015 (GLOBE NEWSWIRE) -- Numerex Corp (Nasdaq:NMRX), a leading provider of on-demand and interactive machine-to-machine
More informationHP Q4 FY15 Earnings Announcement
HP Q4 FY15 Earnings Announcement November 24, 2015 http://www.hp.com/investor/home Forward-looking statements This presentation contains forward-looking statements that involve risks, uncertainties and
More informationRepligen Reports Third Quarter 2015 Financial Results
Repligen Corporation 41 Seyon Street Building #1, Suite 100 Waltham, Massachusetts 02453 Repligen Reports Third Quarter 2015 Financial Results - Product Sales Increase 31% to $19.8 Million - - Conference
More information4Q15 Earnings February 2016
4Q15 Earnings February 2016 Forward-Looking Statements The statements contained in this presentation that refer to plans and expectations for the next quarter, the full year or the future are forward-looking
More informationGreat Basin Reports 2015 Second Quarter Results and Business Update
Great Basin Reports 2015 Second Quarter Results and Business Update Company Reports 122 Revenue-Generating Customers, Reaffirms Guidance of 170-180 Customers by Year End SALT LAKE CITY, August 12, 2015
More informationCONE Midstream Partners LP. 1Q 2016 Earnings May 5, 2016
CONE Midstream Partners LP 1Q 2016 Earnings May 5, 2016 Disclaimer Forward Looking Statements This presentation contains forward-looking statements within the meaning of the federal securities laws. Statements
More informationThe Future of Consumer Health Care
The Future of Consumer Health Care Coming Together To Lead The Consumer Health Care Industry 2 Creating a New Business Model in Consumer Health Care 3 Serve More Consumers In More Parts of the World, More
More informationEquipping your Forecasting Toolkit to Account for Ongoing Changes
Equipping your Forecasting Toolkit to Account for Ongoing Changes Presented by: Roger Parlett Supply Chain Manager January 23, 2014 Overview Forecast Set-up Objectives of Creating a Forecast Identify Critical
More informationContact: Ken Bond Deborah Hellinger Oracle Investor Relations Oracle Corporate Communications 1.650.607.0349 1.212.508.7935
For Immediate Release Contact: Ken Bond Deborah Hellinger Oracle Investor Relations Oracle Corporate Communications 1.650.607.0349 1.212.508.7935 ken.bond@oracle.com deborah.hellinger@oracle.com ORACLE
More informationSpectra Energy Reports Second Quarter 2008 Results, Net Income Up 51 Percent from Prior Year
Media: Analysts: Molly Boyd (713) 627-5923 (713) 627-4747 (24-hour media line) John Arensdorf (713) 627-4600 Date: August 6, 2008 Spectra Energy Reports Second Quarter 2008 Results, Net Income Up 51 Percent
More informationSunoco Logistics Partners L.P. Second Quarter 2015 Earnings Conference Call August 6, 2015
Sunoco Logistics Partners L.P. Second Quarter 2015 Earnings Conference Call August 6, 2015 Forward-Looking Statements You should review this slide presentation in conjunction with the second quarter 2015
More informationAutobytel 2014 Q4 Results NASDAQ: ABTL February 26, 2015
Autobytel 2014 Q4 Results NASDAQ: ABTL February 26, 2015 Copyright 2015 Autobytel Inc. Safe Harbor Statement and Non-GAAP Disclosures The statements made in the accompanying conference call or contained
More informationRegal Beloit Corporation Third Quarter 2014 Earnings Conference Call
Regal Beloit Corporation Third Quarter 2014 Earnings Conference Call November 4, 2014 Mark Gliebe Chairman and Chief Executive Officer Jon Schlemmer Chief Operating Officer Chuck Hinrichs Vice President
More information2014 Wells Fargo Healthcare Conference June 17, 2014 NYSE: Q
2014 Wells Fargo Healthcare Conference June 17, 2014 NYSE: Q Copyright 2013 Quintiles Forward Looking Statements and Use of Non-GAAP Financial Measures This presentation contains forward-looking statements
More informationPerformance Food Group Company Reports Second-Quarter and First-Half Fiscal 2016 Results; Reaffirms Full-Year Fiscal 2016 Adjusted EBITDA Outlook
NEWS RELEASE For Immediate Release February 3, 2016 Investors: Michael D. Neese VP, Investor Relations (804) 287-8126 michael.neese@pfgc.com Media: Joe Vagi Manager, Corporate Communications (804) 484-7737
More informationSpectra Energy Reports Second Quarter 2007 Results
Media: Molly Boyd (713) 627-5923 (713) 627-4747 (24-hour media line) Analysts: John Arensdorf (713) 627-4600 Date: August 6, 2007 Spectra Energy Reports Second Quarter 2007 Results Second quarter reported
More informationWealth Management and Securities Services
U.S. Bancorp Investor Day Wealth Management and Securities Services Terry Dolan Vice Chairman September 12, 2013 # Forward-looking Statements and Additional Information The following information appears
More informationSECOND QUARTER 2014 EARNINGS CONFERENCE CALL
SECOND QUARTER 2014 EARNINGS CONFERENCE CALL July 31, 2014 SAFE HARBOR Statements in this presentation, including those related to the outlook for 2014 and beyond, the continuing integration of Motorola
More informationLow Price Environment and the Impact on Unconventional Resource Developments
Low Price Environment and the Impact on Unconventional Resource Developments Mark Nelson Vice President Commercial & Communications ConocoPhillips China October 16, 2015 Cautionary Statement The following
More informationLockheed Martin Corporation
Lockheed Martin Corporation Portfolio Shaping Actions & 2 nd Quarter 2015 Financial Results July 20, 2015 11:00 am EDT Webcast login at www.lockheedmartin.com/investor Webcast replay & podcast available
More informationLockheed Martin Corporation
Lockheed Martin Corporation 4 th Quarter 2015 Financial Results Conference Call 11:00 am EST Webcast login at www.lockheedmartin.com/investor Webcast replay & podcast available by 2:00 p.m. EST at www.lockheedmartin.com/investor.
More informationAnnual Meeting of Shareholders
Annual Meeting of Shareholders William M. Brown Chairman, President & Chief Executive Officer 10/24/2014 1 Forward-looking statements Statements in this presentation that are not historical facts are forward-looking
More informationClinical Trial Trends Outline Complexity for Supply Chain. Scott Ohanesian, VP Commercial Operations APAC Email: Scott.Ohanesian@marken.
Clinical Trial Trends Outline Complexity for Supply Chain Scott Ohanesian, VP Commercial Operations APAC Email: Scott.Ohanesian@marken.com 29 May 2013 Biotechnology Sales on the Rise Source: EvaluatePharma
More informationAmgen 2008 Annual Report and Financial Summary
Amgen 2008 Annual Report and Financial Summary Pioneering science delivers vital medicines About Amgen Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology
More informationBlackBerry Reports Software and Services Growth of 106 Percent for Q4 and 113 Percent for Fiscal 2016
April 1, FOR IMMEDIATE RELEASE BlackBerry Reports Software and Services Growth of 106 Percent for Q4 and 113 Percent for Fiscal Company reports positive free cash flow for eighth consecutive quarter and
More informationDriving Shareholder Value
Driving Shareholder Value Business Model and Capital Allocation Strategy Wolfgang Nickl CFO, Western Digital September 13, 2012 SAFE HARBOR Forward-Looking Statements This presentation contains forward-looking
More informationTesla Motors, Inc. Fourth Quarter & Full Year 2013 Shareholder Letter
Tesla Motors, Inc. Fourth Quarter & Full Year 2013 Shareholder Letter Record 6,892 Model S vehicles sold and delivered in Q4 World s highest Consumer Reports customer satisfaction score of 99/100 Q4 auto
More informationInvestors/Analysts Conference London/New York, February 2012 Ian Bishop
Investors/Analysts Conference London/New York, February 2012 Ian Bishop This presentation contains certain forward-looking statements. These forward-looking statements may be identified by words such as
More informationSpectra Energy Reports Fourth Quarter and Year-End 2011 Results
Media: Analysts: Wendy Olson (713) 627-4072 (713) 627-4747 (24-hour media line) John Arensdorf (713) 627-4600 Date: February 2, 2012 Spectra Energy Reports Fourth Quarter and Year-End 2011 Results Company
More informationBIOLIFE SOLUTIONS INC
SECURITIES & EXCHANGE COMMISSION EDGAR FILING BIOLIFE SOLUTIONS INC Form: 8-K Date Filed: 2016-01-07 Corporate Issuer CIK: 834365 Copyright 2016, Issuer Direct Corporation. All Right Reserved. Distribution
More informationPRODUCT RETURN POLICY
PRODUCT RETURN POLICY Effective Date: October, 27, 2015 This Product Return Policy ( Product Return Policy ) is for all Products ( Product or Products ) distributed in the United States by Amgen USA Inc.
More informationClinical Supply Chain Management - Technologies such as IVRS, CTMS, EDC and RFID Enhance Drug Supply Management
Brochure More information from http://www.researchandmarkets.com/reports/2226324/ Clinical Supply Chain Management - Technologies such as IVRS, CTMS, EDC and RFID Enhance Drug Supply Management Description:
More informationBlackBerry Reports 2015 Fiscal First Quarter GAAP Profitability
NEWS RELEASE FOR IMMEDIATE RELEASE June 19, BlackBerry Reports 2015 Fiscal First Quarter GAAP Profitability Waterloo, ON BlackBerry Limited (NASDAQ: BBRY; TSX: BB), a global leader in mobile communications,
More informationINTRODUCTION. Viral shedding is crucial for Gene Therapy Products Safety linked with shedding data
INTRODUCTION Viral shedding is crucial for Gene Therapy Products Safety linked with shedding data For the patient For families and friends For the environment No treatment possible without good safety
More informationOpenText Announces Acquisition of GXS Transaction Summary Presentation
OpenText Announces Acquisition of GXS Transaction Summary Presentation November 5, 2013 Safe Harbor Statement Certain statements in this press release, including statements regarding the proposed transaction
More informationVCR License Consolidation - Correctly Preparing The Annual Revenue Growth
VMW Q1-2015 Earnings Conference Call 2014 VMware Inc. All rights reserved. Speakers Slide 2 Paul Ziots VP, Investor Relations Pat Gelsinger CEO Carl Eschenbach President & COO Jonathan Chadwick CFO & COO
More information- Company Also Expects Leverage Ratio to Drop Below 6x by the End of Fiscal 2016 and Below 5x by the End of Fiscal 2017 -
Performance Sports Group Expects Working Capital and Profitability Improvement Initiatives to Reduce Debt by Approximately $40 Million in the Second Half of Fiscal 2016 - Company Also Expects Leverage
More informationLockheed Martin 4 th Quarter 2014 Financial Results Conference Call
Lockheed Martin 4 th Quarter 2014 Financial Results Conference Call January 27, 2015 11:00 a.m. EST Webcast login at www.lockheedmartin.com/investor Webcast replay & podcast available by 2:00 p.m. EST
More informationEnterprise Revenue Focus
U.S. Bancorp Investor Day Enterprise Revenue Focus Mac McCullough EVP and Chief Strategy Officer September 12, 2013 # Forward-looking Statements and Additional Information The following information appears
More informationlast page of this release. 3 Operating margin is calculated as operating income divided by net revenues.
By: EARNINGS RELEASE Expeditors International of Washington, Inc. 1015 Third Avenue, Suite 1200 Seattle, Washington 98104 CONTACTS: R. Jordan Gates Bradley S. Powell President and Chief Operating Officer
More informationRiverbed Technology, Inc. Reports Third Quarter 2007 Financial Results
Contact: Randy Gottfried, Chief Financial Officer Chris Danne ir@riverbed.com chris@blueshirtgroup.com Riverbed Technology, Inc. The Blueshirt Group 415-247-6397 415-217-7722 Riverbed Technology, Inc.
More informationIncome Statement Format and Disclosures 2007 Conference call for Financial Analysts, November 2007 Ian Bishop
Income Statement Format and Disclosures 2007 Conference call for Financial Analysts, November 2007 Ian Bishop This presentation contains certain forward-looking statements. These forward-looking statements
More informationClinical Supply Chain Management Driving Operational Performance
Clinical Supply Chain Management Driving Operational Performance July 2010 PwC Your presenters EER1 Ellen Reilly Managing Director Pharma & Life Sciences Advisory Services 400 Campus Drive Florham Park,
More informationQ4 2015 Financial Results
Q4 2015 Financial Results January 28, 2016 Copyright Fortinet Inc. All rights reserved. Safe Harbor Statement Information, statements and projections contained in these presentation slides and related
More informationRegal Beloit Corporation Second Quarter 2014 Earnings Conference Call
Regal Beloit Corporation Second Quarter 2014 Earnings Conference Call July 30, 2014 Mark Gliebe Chairman and Chief Executive Officer Jon Schlemmer Chief Operating Officer Chuck Hinrichs Vice President
More informationSunGard Announces Third Quarter 2006 Results
For more information, contact: Michael Ruane Eric Erickson Kris Block Tel: 484-582-5405 Tel: 484-582-5480 Tel: 484-582-5505 michael.ruane@sungard.com eric.erickson@sungard.com kris.block@sungard.com SunGard
More informationSpectra Energy Reports Third Quarter 2007 Results
Media: Molly Boyd (713) 627-5923 (713) 627-4747 (24-hour media line) Analysts: John Arensdorf (713) 627-4600 Date: November 6, 2007 Spectra Energy Reports Third Quarter 2007 Results Third quarter ongoing
More informationStaples, Inc. Announces First Quarter 2016 Performance
Media Contact: Mark Cautela 508-253-3832 Investor Contact: Chris Powers/Scott Tilghman 508-253-4632/1487 Staples, Inc. Announces First Quarter 2016 Performance FRAMINGHAM, Mass., May 18, 2016 Staples,
More information2011 Annual Stockholder Meeting October 12, 2011
2011 Annual Stockholder Meeting October 12, 2011 Jeff Henley Chairman of the Board Safe Harbor Statement Statements in this presentation relating to Oracle's or its Board of Directors
More informationSYNOPSYS POSTS FINANCIAL RESULTS FOR FOURTH QUARTER AND FISCAL YEAR 2007
PRESS RELEASE INVESTOR CONTACT: Lisa L. Ewbank Synopsys, Inc. 650-584-1901 EDITORIAL CONTACT: Yvette Huygen Synopsys, Inc. 650-584-4547 yvetteh@synopsys.com SYNOPSYS POSTS FINANCIAL RESULTS FOR FOURTH
More informationACI Worldwide, Inc. Reports Financial Results for the Quarter Ended March 31, 2014
News Release ACI Worldwide, Inc. Reports Financial Results for the Quarter Ended March 31, 2014 HIGHLIGHTS SNET bookings of $122 million, up 59% from Q1 last year Recurring revenue up 57% from last year,
More informationSuccessFactors Announces First Quarter Fiscal 2010 Results
CONTACTS: CONTACT: Dominic Paschel SuccessFactors, Inc. Global Public & Investor Relations 415-262-4641 dpaschel@successfactors.com SuccessFactors Announces First Quarter Fiscal 2010 Results Q110 bookings
More informationVMware Reports First Quarter 2015 Results
VMware Reports First Quarter 2015 Results - Year-over-Year Revenue Growth of 11% to $1.51 Billion; up 13% on a constant currency basis - GAAP EPS of $0.45; Non-GAAP EPS of $0.86, an increase of 7% year
More informationFord Credit Earns Full-Year 2014 Pre-Tax Profit of $1.9 Billion; Net Income of $1.7 Billion*
Ford Credit Earns Full-Year Pre-Tax Profit of $1.9 Billion; Net Income of $1.7 Billion* DEARBORN, Mich., Jan. 29, 2015 Ford Motor Credit Company reported a pre-tax profit of $1.9 billion in, its highest
More informationContact: Ken Bond Deborah Hellinger Oracle Investor Relations Oracle Corporate Communications 1.650.607.0349 1.212.508.7935
For Immediate Release Contact: Ken Bond Deborah Hellinger Oracle Investor Relations Oracle Corporate Communications 1.650.607.0349 1.212.508.7935 ken.bond@oracle.com deborah.hellinger@oracle.com ORACLE
More informationFirst Quarter Fiscal Year 2016 Results Conference Call
February 4, 2016 First Quarter Fiscal Year 2016 Results Conference Call Bradley H. Feldmann President and Chief Executive Officer John Jay D. Thomas Executive Vice President and Chief Financial Officer
More informationIMMUNOMEDICS, 300 The American Road, Morris Plains, New Jersey 07950 (973) 605-8200 Fax (973) 605-8282
IMMUNOMEDICS, INC. 300 The American Road, Morris Plains, New Jersey 07950 (973) 605-8200 Fax (973) 605-8282 IMMUNOMEDICS ANNOUNCES FIRST QUARTER FISCAL 2014 RESULTS AND CLINICAL PROGRAM DEVELOPMENTS Morris
More informationPractical Applications for Clinical Demand and Operations Planning
Practical Applications for Clinical Demand and Operations Planning Randy Schwemmin Genentech Clinical Demand and Supply Planning Biotech Supply Chain Academy 8 November 2011 Agenda Vision for Clinical
More informationIntroduction. VP, Sales in a Global Courier Company
ARTICLE AUGUST 2014 Abstract: Impact analysis of Just in Time packaging and labeling on clinical supply chain Clinical supply chain is in intense pressure for better management due to factors like globalization
More informationChina Distance Education Holdings Limited Reports First Quarter Fiscal Year 2016 Financial Results
China Distance Education Holdings Limited Reports First Quarter Fiscal Year 2016 Financial Results - Revenue Up 13.5% Year-Over-Year to $24.4 Million, Exceeding Guidance - Cash Receipts From Online Course
More informationPhilips Capital Markets Day -Group -Healthcare
Philips Capital Markets Day -Group -Healthcare Boston, May 10, 2012 Important information Forward-looking statements This document and the related oral presentation, including responses to questions following
More informationInvestor Presentation NASDAQ:BLFS
Investor Presentation NASDAQ:BLFS Safe Harbor Statement This presentation contains forward-looking statements, including, but not limited to, statements concerning the company s anticipated business and
More informationFourth Quarter 2008 Earnings Acquisition of Communication Services Group Supplemental Information
Fourth Quarter 2008 Earnings Acquisition of Communication Services Group Supplemental Information Forward Looking Statements The statements contained in this release that are not historical facts are forward-looking
More informationSanford C. Bernstein Strategic Decisions Conference. May 2014. Tom Lynch Chairman and Chief Executive Officer
Sanford C. Bernstein Strategic Decisions Conference May 2014 Tom Lynch Chairman and Chief Executive Officer FORWARD-LOOKING STATEMENTS AND NON-GAAP MEASURES Forward-Looking Statements -- This presentation
More informationWe do what we say we will do.
We do what we say we will do. Investor Presentation November 2012 1 Forward-Looking Statements Certain statements in this document are forward-looking statements, which reflect management s current beliefs
More informationQ2-14 Financial Results. July 30, 2014
Q2-14 Financial Results July 30, 2014 Forward-looking Statements & Non-GAAP Measures Information contained in these materials or presented orally on the earnings conference call, either in prepared remarks
More informationH1 2009 Earnings Release
H1 2009 Earnings Release Olivier Piou, CEO Jacques Tierny, CFO August 25, 2009 www.gemalto.com Disclaimer Forward-Looking Statements This communication contains certain statements that are neither reported
More informationWe do what we say we will do.
We do what we say we will do. Investor Presentation 1 November 2013 Forward-Looking Statements Certain statements in this document are forward-looking statements, which reflect management s current beliefs
More information